TitleAuthorPublication DatePublisherType
    Is there truly an increase in risk of cardiovascular and hematological adverse events with vascular endothelial growth factor receptor tyrosine kinase inhibitors?  Furuya-Kanamori, Luis; Doi, Suhail Ar; Onitilo, Adedayo; Akhtar, Saghir2019Taylor & FrancisArticle